Skip to main content
Clinical Trials/NCT07110207
NCT07110207RecruitingNot Applicable

Single-centre Descriptive Study of Taste in Frontotemporal Lobar Degeneration Through the Analysis of Taste Evoked Potentials

Centre Hospitalier Universitaire Dijon1 site in 1 country20 target enrollmentStarted: August 18, 2025Last updated:
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
20
Locations
1
Primary Endpoint
Average latency of taste evoked potentials

Study Overview

Brief Summary

The FRONTAL-PEG study focuses on taste perception in frontotemporal lobar degeneration (FTLD). This neurodegenerative disease, characterised by progressive loss of nerve cells, is the second leading cause of dementia after Alzheimer's disease.

Patients with FTLD often experience olfactory disorders (= sense of smell) and eating disorders: increased appetite, increased food intake and excessive consumption of sugary foods and snacking. This often leads to excessive weight gain. These eating disorders are still poorly understood at present.

In this context, we hypothesise that an alteration in the gustatory pathway - i.e. the way in which the brain perceives taste - could contribute to the eating disorders frequently observed in frontotemporal dementia (FTD), particularly in the marked attraction to sweet foods. We therefore wish to objectively evaluate the taste response to a sweet solution (sucrose) in patients with FTLD, using taste evoked potentials (TEPs). Taste evoked potentials are a reliable and reproducible technique for assessing brain activity in response to taste stimulation. One of their advantages is that they are non-invasive.

This study will document, for the first time in this disease, the characteristics of cortical (brain) processing of taste information.

The FRONTAL-PEG study is an interventional, regional, single-centre study conducted at the Dijon University Hospital, in collaboration with the CMRR (Memory, Resources and Research Centre) and the CSGA (Centre for Taste and Food Sciences).

All investigations are carried out at the CSGA (building adjacent to the Dijon University Hospital), with the exception of blood tests, which are carried out at the Dijon University Hospital.

The total duration of participation in the study is one morning. No follow-up is planned at the end of the study.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Person who has given their free and informed consent
  • Person of legal age
  • Fasting > 2 hours before PEG measurement
  • Body Mass Index (BMI) < 30 kg/m² (according to medical record data)
  • DLFT: diagnostic criteria for established or probable DLFT

Exclusion Criteria

  • Persons not affiliated with or not covered by a social security scheme
  • Persons subject to legal protection measures (guardianship, trusteeship)
  • Persons subject to judicial protection measures
  • Pregnant women, women in labour or breastfeeding women
  • MMSE score < 15 and/or MoCA score < 10
  • Known COVID-19 infection within 6 months prior to inclusion
  • Active smokers (> 4 cigarettes per day on a regular basis)
  • Subject with a pacemaker (contraindication for bioelectrical impedance analysis)
  • Subject with diabetes (type 1 or type 2)
  • Taking medication (during the study) that interferes with taste

Arms & Interventions

Patients with frontotemporal lobar degeneration

Experimental

Intervention: Blood test (Biological)

Patients with frontotemporal lobar degeneration

Experimental

Intervention: Interrogation of the subject (Other)

Patients with frontotemporal lobar degeneration

Experimental

Intervention: Cognitive assessment (Other)

Patients with frontotemporal lobar degeneration

Experimental

Intervention: Nutritional assessment (Other)

Patients with frontotemporal lobar degeneration

Experimental

Intervention: Taste tests (Other)

Patients with frontotemporal lobar degeneration

Experimental

Intervention: Sucrose taste detection test (Other)

Outcomes

Primary Outcomes

Average latency of taste evoked potentials

Time Frame: After a fasting period of at least two hours

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials